Also listed on Glaxo Group Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ended no later than Nov 14, 2026 · Medium confidence
20-year base term ended Oct 6, 2026
Oct 6, 2006
Nov 14, 2026
Dec 21, 2010
This patent's term runs 39 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 6, 2006, when application PCT/EP2006/009746, the earliest non-provisional in its chain, was filed (this one was filed Jul 19, 2008) | Oct 6, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +39 days, USPTO patent term adjustment record | Nov 14, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | no later than Nov 14, 2026 | Medium confidence |
Partial family
| Application PCT/EP2006/009746 | PCT application no patent term | no patent term |
| US 7,855,218 | this patent no later than Nov 2026 | no later than Nov 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 28, 2008 Reel 21456, frame 287 | Alvaro, Giuseppe; Andreotti, Daniele; Bergauer, Markus; Giovannini, Riccardo; Marasco, Agostino | GlaxoSmithKline S.p.A. | Assignment of Assignor's Interest |
| Aug 28, 2008 Reel 21456, frame 326 | GlaxoSmithKline S.p.A. | Glaxo Group Limited | Assignment of Assignor's Interest |
| Feb 9, 2011 Reel 25776, frame 344 | Glaxo Group Limited | Convergence Pharmaceuticals Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 14, 2026. We will not guess the cap.